Tudor Investment Corp
LUMO

Tudor Investment Corp’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Tudor Investment Corp’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,524
Closed -$414K – 1316
2017
Q3 		$414K Buy
4,524
+200
+5% +$15.3K 0.01% 709
2017
Q2 		$286K Buy
+4,324
New +$535K 0.01% 774
2016
Q3 		– Sell
-3,933
Closed -$399K – 1787
2016
Q2 		$399K Buy
3,933
+1,933
+97% +$240K 0.01% 997
2016
Q1 		$328K Buy
2,000
+1,300
+186% +$264K 0.01% 1236
2015
Q4 		$229K Buy
+700
New +$228K 0.01% 1375
2015
Q3 		– Sell
-633
Closed -$252K – 1790
2015
Q2 		$252K Buy
633
+35
+6% +$14.9K 0.01% 1209
2015
Q1 		$294K Buy
+598
New +$232K 0.01% 1064

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tudor Investment Corp's LUMO Position: Q4 2017 in Review

Tudor Investment Corp sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2017, closing a stake of 4,524 shares — an estimated $414K sold.

Tudor Investment Corp first reported a position in LUMO in Q1 2015 and held it in 7 quarters. The position peaked at $414K in Q3 2017. 130 funds tracked by Wall St. Rank hold LUMO as of Q4 2017.

  • Tudor Investment Corp reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Tudor Investment Corp sold 4,524 Lumos Pharma, Inc. Common Stock shares in Q4 2017, an estimated $414K.
  • Tudor Investment Corp first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2015 and held it in 7 quarters.
  • Tudor Investment Corp's Lumos Pharma, Inc. Common Stock position peaked at $414K in Q3 2017.
  • 130 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2017.

Based on Tudor Investment Corp's 13F filing for Q4 2017, filed 14 Feb 2018.